MARKET

PYPD

PYPD

Polypid Ltd.
NASDAQ
4.333
-0.047
-1.07%
Opening 12:20 05/15 EDT
OPEN
4.300
PREV CLOSE
4.380
HIGH
4.490
LOW
4.250
VOLUME
49.52K
TURNOVER
--
52 WEEK HIGH
5.12
52 WEEK LOW
2.440
MARKET CAP
82.69M
P/E (TTM)
-2.0736
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Aptevo Therapeutics (APVO)
TipRanks · 1d ago
PolyPid (PYPD) Receives a Buy from H.C. Wainwright
TipRanks · 1d ago
PolyPid Earnings Call: NDA Momentum Amid Cash Strain
TipRanks · 1d ago
PolyPid reports Q1 EPS (35c), consensus (43c)
TipRanks · 1d ago
PolyPid Q1 2026 Earnings Call: Complete Transcript
Benzinga · 2d ago
PolyPid Advances D-PLEX₁₀₀ Toward FDA Review as Q1 2026 Loss Narrows and Debt Is Retired
TipRanks · 2d ago
PolyPid Q1 FY26 net loss narrows 7.61% to $7.7 million
PUBT · 2d ago
POLYPID LTD - U.S. COMMERCIAL PARTNERSHIP DISCUSSIONS FOR D-PLEX100 IN LATE STAGES
Reuters · 2d ago
More
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Webull offers Polypid Ltd stock information, including NASDAQ: PYPD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PYPD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PYPD stock methods without spending real money on the virtual paper trading platform.